Literature DB >> 16423569

Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters.

Haruhiko Kondoh1, Yoshiki Sawa, Shigeru Miyagawa, Satoru Sakakida-Kitagawa, Imran A Memon, Naomasa Kawaguchi, Nariaki Matsuura, Tatsuya Shimizu, Teruo Okano, Hikaru Matsuda.   

Abstract

OBJECTIVES: Cell therapy is a promising strategy for ischemic cardiomyopathy. However, the direct injection method has limitations for generalized cell delivery, especially in dilated cardiomyopathy (DCM). We hypothesized that a sheet-shaped myoblast graft would be superior to direct injection for improving cardiac performance in DCM.
METHODS: Male 27-week-old BIO TO-2 (DCM) hamsters that showed moderate cardiac remodeling were used as recipients. Myoblasts isolated from BIO F1B hamsters were cultured on dishes coated with poly(N-isopropylacrylamide), a temperature-responsive polymer, and spontaneously detached as a sheet-shaped graft at 20 degrees C without enzymatic treatment. Three different therapies were conducted: (1) sheet-shaped myoblast graft implantation (S group, n=29); (2) myoblast injection (M group, n=28); and (3) sham operation (C group, n=28). In the S group, two sheet-shaped myoblast grafts were implanted on the left ventricle (LV) wall, and in the M group, myoblasts were injected into the right ventricle (RV) and LV walls.
RESULTS: After the sheet-shaped myoblast grafts were implanted, echocardiography demonstrated that the dilated LV dimension was significantly reduced, whereas the hearts in other groups showed a progression of LV dilation. The fractional shortening in the M and C groups decreased significantly while that in the S group was maintained at the preoperative level for 3 months after the operation. Histological examination demonstrated that in the S group, the LV wall thickness was increased, with viable myoblasts, and myocardial fibrosis was decreased compared with the other groups. Immunohistochemical staining demonstrated alpha-sarcoglycan and beta-sarcoglycan expression on the basement membrane of the cardiomyocytes in the S group but not in the other groups. The life expectancy was significantly prolonged in the S group.
CONCLUSION: Sheet-shaped myoblast graft implantation improved cardiac performance and prolonged life expectancy, associated with a reduction in myocardial fibrosis and re-organization of the cytoskeletal proteins in DCM hamsters. Thus, sheet-shaped autologous myoblast graft implantation may induce restoration of the heart in DCM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423569     DOI: 10.1016/j.cardiores.2005.11.005

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  35 in total

1.  Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model.

Authors:  D Ladage; I C Turnbull; K Ishikawa; Y Takewa; K Rapti; C Morel; I Karakikes; L Hadri; J Müller-Ehmsen; K D Costa; R J Hajjar; Y Kawase
Journal:  Gene Ther       Date:  2011-04-21       Impact factor: 5.250

Review 2.  Stem cell therapies for heart disease: why do we need bioengineers?

Authors:  Nenad Bursac
Journal:  IEEE Eng Med Biol Mag       Date:  2007 Jul-Aug

3.  Effect of substrate storage conditions on the stability of "Smart" films used for mammalian cell applications.

Authors:  Blake M Bluestein; Jamie A Reed; Heather E Canavan
Journal:  Appl Surf Sci       Date:  2016-09-01       Impact factor: 6.707

4.  Fibroblast sheets co-cultured with endothelial progenitor cells improve cardiac function of infarcted hearts.

Authors:  Hiroshi Kobayashi; Tatsuya Shimizu; Masayuki Yamato; Kayoko Tono; Haruchika Masuda; Takayuki Asahara; Hiroshi Kasanuki; Teruo Okano
Journal:  J Artif Organs       Date:  2008-10-05       Impact factor: 1.731

Review 5.  Current status of myocardial regeneration therapy.

Authors:  Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-11-07

6.  Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.

Authors:  J Raymond Fitzpatrick; John R Frederick; Ryan C McCormick; David A Harris; Ah-Young Kim; Jeffrey R Muenzer; Alex J Gambogi; Jing Ping Liu; E Carter Paulson; Y Joseph Woo
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-03       Impact factor: 5.209

7.  Engineered skeletal muscle tissue networks with controllable architecture.

Authors:  Weining Bian; Nenad Bursac
Journal:  Biomaterials       Date:  2008-12-12       Impact factor: 12.479

8.  Effect of Electromechanical Stimulation on the Maturation of Myotubes on Aligned Electrospun Fibers.

Authors:  I-Chien Liao; Jason B Liu; Nenad Bursac; Kam W Leong
Journal:  Cell Mol Bioeng       Date:  2008-09-01       Impact factor: 2.321

Review 9.  Cardiac tissue engineering using stem cells.

Authors:  Nenad Bursac
Journal:  IEEE Eng Med Biol Mag       Date:  2009 Mar-Apr

10.  Muscle-derived stem cell sheets support pump function and prevent cardiac arrhythmias in a model of chronic myocardial infarction.

Authors:  Naosumi Sekiya; Kimimasa Tobita; Sarah Beckman; Masaho Okada; Burhan Gharaibeh; Yoshiki Sawa; Robert L Kormos; Johnny Huard
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.